论文部分内容阅读
目的观察临床上应用血必净治疗对于急性心肌梗死(AMI)的疗效。方法将43例AMI患者随机分成治疗组和对照组,治疗组在西医综合治疗的基础上加用血必净注射液,对照组单纯应用西医综合治疗。对比两组患者血清中炎性因子水平,治疗前后心功能分级改善情况,以及临床预后的差异。结果治疗组患者血液中炎性因子水平及患者死亡率均明显低于对照组,心功能改善明显,两组间比较,各项指标差异均有统计学意义(P<0.05)。结论血必净注射液可以降低炎性因子水平,明显改善患者心功能分级,对AMI患者治疗及预后具有积极意义。
Objective To observe the clinical effect of Xuebijing on acute myocardial infarction (AMI). Methods 43 patients with AMI were randomly divided into treatment group and control group. The treatment group was treated with Xuebijing injection on the basis of comprehensive treatment of western medicine. The control group was treated with Western medicine alone. The levels of inflammatory cytokines in the two groups were compared before and after treatment to improve the classification of cardiac function, as well as the difference in clinical prognosis. Results The levels of inflammatory cytokines and mortality in the treatment group were significantly lower than those in the control group, and the cardiac function improved significantly. There was significant difference between the two groups in the indexes (P <0.05). Conclusion Xuebijing injection can reduce the level of inflammatory cytokines, significantly improve the classification of patients with cardiac function, AMI patients with treatment and prognosis of positive.